Cme (CME) Asset Writedowns and Impairment (2016 - 2021)

Cme (CME) has 5 years of Asset Writedowns and Impairment data on file, last reported at -$600000.0 in Q4 2021.

• Asset Writedowns and Impairment for Q4 2021 came in at -$600000.0, up 45.45% year-over-year; the trailing twelve-month figure through Sep 2021 was -$500000.0 (down 101.82% YoY), and the FY2020 annual result was $26.3 million, down 56.96% from the prior year.
• Asset Writedowns and Impairment slipped to -$600000.0 in Q4 2021 per CME's latest filing, from $600000.0 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $39.5 million in Q3 2019 and troughed at -$9.5 million in Q4 2018.
• A 4-year average of $8.7 million and a median of $2.7 million in 2020 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2019 and 2020: Asset Writedowns and Impairment soared 315.79% in 2019, then sank 101.27% in 2020.
• A 4-year view of Asset Writedowns and Impairment shows it stood at -$9.5 million in 2018, then surged by 515.79% to $39.5 million in 2019, then plunged by 102.78% to -$1.1 million in 2020, then soared by 45.45% to -$600000.0 in 2021.
• Business Quant data shows CME's Asset Writedowns and Impairment at -$600000.0 in Q4 2021, $600000.0 in Q3 2021, and -$1.1 million in Q4 2020.